Canada markets closed
  • S&P/TSX

    20,230.96
    -0.34 (-0.00%)
     
  • S&P 500

    4,223.70
    -22.89 (-0.54%)
     
  • DOW

    34,033.67
    -265.63 (-0.77%)
     
  • CAD/USD

    0.8150
    +0.0003 (+0.04%)
     
  • CRUDE OIL

    71.67
    -0.48 (-0.67%)
     
  • BTC-CAD

    47,616.96
    -1,611.48 (-3.27%)
     
  • CMC Crypto 200

    965.64
    -26.83 (-2.70%)
     
  • GOLD FUTURES

    1,824.30
    -37.10 (-1.99%)
     
  • RUSSELL 2000

    2,314.69
    -5.38 (-0.23%)
     
  • 10-Yr Bond

    1.5690
    +0.0700 (+4.67%)
     
  • NASDAQ futures

    13,912.25
    -69.00 (-0.49%)
     
  • VOLATILITY

    18.15
    +1.13 (+6.64%)
     
  • FTSE

    7,184.95
    +12.47 (+0.17%)
     
  • NIKKEI 225

    28,906.75
    -384.26 (-1.31%)
     
  • CAD/EUR

    0.6787
    -0.0002 (-0.03%)
     

Actinium: Q1 Earnings Snapshot

·1 min read

NEW YORK (AP) _ Actinium Pharmaceuticals Inc. (ATNM) on Friday reported a loss of $5.3 million in its first quarter.

The New York-based company said it had a loss of 29 cents per share.

The cancer drug developer posted revenue of $622,000 in the period.

Actinium shares have dropped 9% since the beginning of the year. In the final minutes of trading on Friday, shares hit $7.09, an increase of 31% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATNM at https://www.zacks.com/ap/ATNM

The Associated Press

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting